Adam joined the Zymtronix Board of Directors in 2020, after almost 30 years with Novozymes where he was President for North America until November 2019. He started with Novozymes in 1991, holding numerous roles from Recovery Engineer, Supply Chain Director for the Americas, Global Capacity Planning and North America leadership. Holding a bachelor in Chemical Engineering from the University of Arkansas, his global expertise in enzyme innovation, markets, production, sales, and logistics is unrivaled and will be instrumental in the next phase of growth of Zymtronix.